• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA DIFFUSICS 22G X 1.00 IN; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. BD NEXIVA DIFFUSICS 22G X 1.00 IN; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 383591
Medical Device Problem Code Material Perforation (2205)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/24/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that bd nexiva diffusics 22g x 1.00 in needle through catheter.It was reported by customer that "when partially pulling back needle in 22 gauge iv and reinserting, needle is puncturing iv catheter and splitting catheter in two." verbatim: rcc received a complaint via email.Email(s) attached.When partially pulling back needle in 22 gauge iv and reinserting, needle is puncturing iv catheter and splitting catheter in two.Has happened multiple times with this lot number of iv sets.Lot# 4303911.Additional information received on 24th june 2025: it happened on 2 different patients and then was recreated by poking a saline bag.
 
Additional Manufacturer Narrative
H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
 
Event or Problem Description
No additional information.
 
Additional Manufacturer Narrative
Investigation results: our quality engineer inspected the 2 photos submitted for evaluation.The reported issue of needle through catheter was confirmed upon inspection of the photos.Analysis of the sample showed that the used device has the needle protruding through the catheter.However, bd cannot confirm the cause of the failure to manufacturing since controls are in place throughout the device assembly that are capable of segregating defects of this type.A review of our risk management documentation was performed and indicates that the potential risk of the reported event was assessed appropriately.Production records were reviewed, and this batch meets our manufacturing specification requirements.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD NEXIVA DIFFUSICS 22G X 1.00 IN
Common Device Name
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX 
Manufacturer (Section G)
BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.
periferico luis donaldo
colosio no. 579
nogales
MX  
Manufacturer Contact
helen cox (mdr)
75 north fairway drive
vernon hills, IL 60061
8473935694
MDR Report Key22373276
Report Number9610847-2025-00207
Device Sequence Number18149055
Product Code FOZ
UDI-Device Identifier00382903835911
UDI-Public(01)00382903835911(11)241118(17)271031(10)4303911
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
K173354
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/18/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number383591
Device Lot Number4303911
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/12/2025
Supplement Date Received by Manufacturer12/18/2025
Initial Report FDA Received Date07/01/2025
Supplement Report FDA Received Date12/24/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured11/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-